triiodothyronine has been researched along with Follicle Stimulating Hormone, Inappropriate Secretion in 7 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thyrotropin (TSH)-secreting pituitary adenoma (TSHoma) and resistance to thyroid hormone (RTH) are two forms of inappropriate TSH secretion." | 1.33 | Thyroid color flow Doppler sonography: an adjunctive tool for differentiating patients with inappropriate thyrotropin (TSH) secretion due to TSH-secreting pituitary adenoma or resistance to thyroid hormone. ( Bartalena, L; Bogazzi, F; Cosci, C; Gasperi, M; Macchia, E; Manetti, L; Martino, E; Rossi, G; Sardella, C; Tomisti, L; Vitti, P, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsunekawa, K | 1 |
| Murakami, M | 1 |
| Macchia, E | 2 |
| Lombardi, M | 1 |
| Raffaelli, V | 1 |
| Piaggi, P | 1 |
| Macchia, L | 1 |
| Scattina, I | 1 |
| Martino, E | 2 |
| WERNER, SC | 1 |
| SPOONER, M | 1 |
| HAMILTON, H | 1 |
| Bogazzi, F | 1 |
| Manetti, L | 1 |
| Tomisti, L | 1 |
| Rossi, G | 1 |
| Cosci, C | 1 |
| Sardella, C | 1 |
| Bartalena, L | 1 |
| Gasperi, M | 1 |
| Vitti, P | 1 |
| Yamada, T | 1 |
| Tsukui, T | 1 |
| Ikejiri, K | 1 |
| Yukimura, Y | 1 |
| Kotani, M | 1 |
| Pechatnikov, LM | 1 |
| Nieschlag, E | 1 |
| Usadel, KH | 1 |
| Kley, HK | 1 |
| Schwedes, U | 1 |
| Herrmann, J | 1 |
| Schöffling, K | 1 |
| Krüskemper, HL | 1 |
1 review available for triiodothyronine and Follicle Stimulating Hormone, Inappropriate Secretion
| Article | Year |
|---|---|
[Thyroid disease caused by receptor abnormality].
Topics: Biomarkers; Humans; Hyperpituitarism; Hypothyroidism; Molecular Diagnostic Techniques; Mutation; Thy | 2014 |
6 other studies available for triiodothyronine and Follicle Stimulating Hormone, Inappropriate Secretion
| Article | Year |
|---|---|
Clinical and genetic characteristics of a large monocentric series of patients affected by thyroid hormone (Th) resistance and suggestions for differential diagnosis in patients without mutation of Th receptor β.
Topics: Adenoma; Adolescent; Adult; Cohort Studies; Diagnosis, Differential; Female; Glycoprotein Hormones, | 2014 |
Further evidence that hyperthyroidism (Graves' disease) is not hyperpituitarism: effects of triiodothyronine and sodium iodide.
Topics: Graves Disease; Humans; Hyperpituitarism; Hyperthyroidism; Sodium Iodide; Triiodothyronine | 1955 |
Thyroid color flow Doppler sonography: an adjunctive tool for differentiating patients with inappropriate thyrotropin (TSH) secretion due to TSH-secreting pituitary adenoma or resistance to thyroid hormone.
Topics: Adenoma; Adult; Aged; Drug Resistance; Female; Humans; Hyperpituitarism; Male; Middle Aged; Pituitar | 2006 |
Volume of sella turcica in normal subjects and in patients with primary hypothyroidism and hyperthyroidism.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Humans; Hyperpituitarism; Hyperthyroidism; Hypot | 1976 |
[Significance of hypophyseo-thyroid disorders in chronic obstructive bronchitis].
Topics: Adult; Aged; Bronchitis; Female; Humans; Hyperpituitarism; Hypothyroidism; Lung Diseases, Obstructiv | 1989 |
[Induction of biologically ineffective hyperactivity and hypertrophy of endocrine glands by active immunisation against the hormone produced. A new pathogenetic mechanism].
Topics: Animals; Antibody Formation; Binding Sites, Antibody; Endocrine System Diseases; Feedback; Hyperpitu | 1973 |